Shishir: Understanding Seasonal Respiratory Patterns in Infants and Young Children

Shishir is the sixth season in the traditional Hindu Panchang calendar, spanning mid-January to mid-March (approximately January 14–March 13) across most Indian regions. During this period, ambient temperatures frequently dip between 5°C and 12°C at night—especially in northern states like Punjab, Haryana, and Uttar Pradesh—while daytime humidity drops below 40%. For infants under 12 months, these environmental shifts correlate with a documented 37% increase in outpatient visits for bronchiolitis and a 2.4-fold higher hospitalization rate for respiratory syncytial virus (RSV) compared to the preceding Hemant season. This article synthesizes 15 years of frontline pediatric nursing observations, peer-reviewed epidemiological data from the Indian Journal of Pediatrics (2021–2023), and clinical guidance from the American Academy of Pediatrics (AAP) and World Health Organization (WHO) to provide actionable, physiology-informed care strategies for families and clinicians.

What Is Shishir—and Why Does It Matter for Infant Health?

Shishir translates literally to "frost" or "cold dew" and reflects the climatic reality of late winter: clear skies, sharp diurnal temperature swings, and persistent ground frost in high-altitude zones like Shimla and Srinagar. Unlike Western meteorological seasons defined solely by temperature averages, Shishir incorporates lunar cycles, wind patterns (notably the northwesterly 'Himachali' breeze), and regional agricultural cues—such as mustard flowering and wheat earing—that influence indoor air quality and pathogen transmission dynamics. From a developmental physiology perspective, infants’ immature thermoregulatory systems—characterized by high surface-area-to-body-mass ratio (300 cm²/kg vs. adult 200 cm²/kg), limited brown adipose tissue reserves, and underdeveloped shivering response—make them disproportionately vulnerable during Shishir’s nocturnal cold snaps. A 2022 multicenter study published in Journal of Tropical Pediatrics confirmed that infants aged 2–6 months exposed to bedroom temperatures below 18°C for >4 hours nightly had 3.1× greater odds of developing wheezing illness within 14 days.

Respiratory Vulnerability: The RSV and Bronchiolitis Surge

The Shishir season aligns precisely with India’s peak RSV activity window. According to surveillance data from the National Institute of Cholera and Enteric Diseases (NICED) in Kolkata, RSV positivity among hospitalized infants rose from 12% in Margashirsha (November–December) to 41% in Shishir (January–February), peaking in the third week of February. This surge coincides with increased indoor crowding, reduced ventilation due to closed windows, and elevated airborne particulate matter (PM2.5 levels averaging 180 µg/m³ in Delhi during Shishir vs. 92 µg/m³ in Ashadha). Critically, RSV infection in infants under 6 months carries heightened risk: 1 in 15 develops apnea, and 1 in 8 requires supplemental oxygen—data consistent across Apollo Hospitals (Chennai), Fortis Memorial Research Institute (Gurgaon), and KEM Hospital (Mumbai) 2023 admissions logs.

Anatomical and Immunological Factors

Infants’ narrow airways—mean tracheal diameter of just 3.5 mm at 3 months—amplify the obstructive effects of viral-induced mucosal edema and mucus hypersecretion. Their immature immune responses further compound risk: neutralizing IgG antibody titers against RSV are only 30–40% of maternal levels by 3 months of age, and CD8+ T-cell cytotoxicity remains suboptimal until after 12 months. This immunologic lag explains why palivizumab prophylaxis—administered monthly at 15 mg/kg IM—is recommended by the Indian Academy of Pediatrics (IAP) for preterm infants born before 29 weeks’ gestation throughout Shishir, even if discharged before January.

Recognizing Early Warning Signs

Parents and caregivers should monitor for subtle indicators beyond classic cough and fever:

• Nasal flaring during feeding (visible widening of nostrils with each breath)
• Intercostal retractions—indentations above clavicles or between ribs—especially when supine
• Feeding intolerance: >25% reduction in intake volume over 24 hours (e.g., dropping from 90 mL/bottle to ≤67 mL)
• Respiratory rate >60 breaths/minute in infants <2 months; >50 breaths/minute in 2–12 month-olds (per WHO Integrated Management of Childhood Illness criteria)
• Saturation drops below 94% on room air, measured via validated pulse oximeters like Nonin PalmSAT 8000F or Masimo Radical-7

Thermoregulation Challenges and Safe Warming Practices

Shishir’s cold-dry air disrupts infants’ evaporative heat loss control. Newborns lose heat 4× faster than adults per kg body weight, primarily through radiation (60%) and convection (30%). Overbundling remains the leading preventable cause of overheating-related SIDS risk during this season: a 2021 IAP audit found 68% of infants admitted for hyperthermia (T >38.0°C axillary) in January–February were dressed in ≥3 layers plus blankets despite ambient room temperatures of 22–24°C. Evidence-based thermal regulation prioritizes layering over bulk: one cotton onesie (200 gsm), one fleece sleeper (280 gsm), and—if needed—a 2.5 TOG Grobag Sleep Bag (by Groswaddle, UK)—which maintains core temperature without restricting hip movement or increasing head-covering risk.

Room Environment Optimization

Maintaining stable microclimates is critical. Ideal nursery conditions during Shishir:

1. Ambient temperature: 20–22°C (measured at crib level, not thermostat height)
2. Relative humidity: 40–60% (monitored via calibrated hygrometers like ThermoPro TP55)
3. Air exchange: ≥4 air changes/hour using HEPA-filtered units (e.g., Blueair Classic 480i or Philips AC2887/30)
4. No direct radiant heat sources (e.g., space heaters, electric blankets, or hot water bottles) within 1 meter of crib

Infants sleeping in rooms with humidity <30% show 2.7× higher incidence of nasal crusting and posterior pharyngeal dryness—factors linked to increased viral adhesion in a 2020 study at PGIMER Chandigarh.

Nutrition and Hydration Strategies

Breastfeeding frequency increases naturally during Shishir: mothers report 12–16 feeds/24 hours versus 8–10 in warmer months. This is physiologically adaptive—colostrum and mature milk IgA concentrations rise 18–22% in response to seasonal pathogen load, per lactation research from St. John’s Medical College (Bangalore). For formula-fed infants, WHO-recommended reconstitution must be strictly followed: 1 level scoop (4.3 g) per 30 mL water—not “extra scoops” to “keep baby warm,” a common but dangerous misconception. Dehydration risk escalates with respiratory illness: infants lose 10–15 mL/kg/day extra insensible fluid during tachypnea. Oral rehydration solution (ORS) use is indicated for any infant with ≥3 loose stools/day or urine output <6 wet diapers/24 hours. WHO low-osmolarity ORS (e.g., Pedialyte AdvancedCare or Nutrilite ORS) contains precise electrolyte ratios: Na⁺ 75 mmol/L, K⁺ 20 mmol/L, glucose 75 mmol/L.

Safe Feeding Modifications During Illness

When congestion impairs suck-swallow-breathe coordination:

• Use ultra-low-flow nipples (e.g., Dr. Brown’s Level 1 Preemie or NUK Smooth Flow)
• Feed upright at 45° angle for 30 minutes post-feed to reduce reflux
• Administer saline drops (0.9% NaCl, 2 drops/nostril) 15 minutes pre-feed, followed by gentle bulb suction
• Offer smaller volumes more frequently (e.g., 15 mL × 8 feeds instead of 30 mL × 4)

Environmental Mitigation: Air Quality and Indoor Pathogen Control

Indoor PM2.5 concentrations in urban Indian homes routinely exceed 120 µg/m³ during Shishir—more than double the WHO 24-hour guideline (25 µg/m³). Key contributors include biomass cooking (even with LPG stoves, secondary emissions persist), kerosene heaters, and incense burning. A controlled trial in 120 Delhi households (2022) demonstrated that installing HEPA + activated carbon filters reduced infant RSV hospitalizations by 31% over Shishir. Equally important is surface decontamination: RSV survives 6–12 hours on stainless steel and plastic, and 45 minutes on human skin. EPA-registered disinfectants effective against RSV include Clorox Healthcare Bleach Germicidal Cleaner (5,000 ppm sodium hypochlorite) and Lysol Disinfectant Spray (0.1% phenol).

Vaccination Timing and Prophylactic Measures

Shishir is the optimal window for catch-up immunizations delayed during monsoon-related access barriers. Per IAP 2023 schedule, pneumococcal conjugate vaccine (PCV) doses should be completed by 3 months of age—ideally administered in December to ensure full protection entering Shishir. Notably, PCV10 (Synflorix, GSK) and PCV13 (Prevnar 13, Pfizer) both demonstrate 82–87% efficacy against vaccine-type invasive pneumococcal disease in Indian infants. For high-risk infants—including those with chronic lung disease (e.g., BPD), congenital heart disease (CHD), or Down syndrome—palivizumab dosing must be timed to cover Shishir’s peak: first dose in mid-January, then monthly through mid-March. Cost considerations matter: at ₹12,400/dose (Apollo Pharmacy, Mumbai), public-sector programs like the National Immunization Program subsidize 100% for qualifying CHD cases.

When to Seek Immediate Care

Red-flag symptoms requiring emergency evaluation:

• Cyanosis (blue lips/tongue) unresponsive to positioning or oxygen
• Apnea lasting >20 seconds or associated with bradycardia (<80 bpm)
• Central nervous system depression: lethargy unresponsive to stimulation, decreased spontaneous movement
• Grunting respirations (>40/min) with nasal flaring and head bobbing
• Capillary refill time >3 seconds despite warm ambient temperature

Delay in seeking care correlates strongly with severity: a 2023 analysis of 1,247 Shishir-related admissions at AIIMS New Delhi found median time from symptom onset to ER presentation was 38 hours for moderate bronchiolitis vs. 72 hours for ICU admissions.

Myth-Busting Common Shishir Care Misconceptions

Decades of clinical experience reveal persistent myths that endanger infants. Rigorous evidence refutes each:

Myth 1: “Putting ghee or mustard oil in nostrils prevents colds.” Reality: Oils coat ciliated epithelium, impairing mucociliary clearance and increasing bacterial adherence. A randomized trial in Varanasi showed 2.9× higher incidence of acute otitis media in oil-treated infants.

Myth 2: “Covering baby’s head with a cap prevents heat loss.” Reality: While head covering reduces radiant loss, thick wool caps cause overheating and CO₂ rebreathing. WHO recommends lightweight cotton caps only outdoors in <10°C ambient air—not indoors or during sleep.

Myth 3: “Steam inhalation thins mucus.” Reality: Uncontrolled steam causes 2nd-degree facial burns in infants. Safer alternatives: cool-mist humidifiers (if RH <40%) or saline nebulization (0.9% NaCl, 2 mL, 3×/day).

Myth 4: “Teething causes fever and respiratory symptoms.” Reality: Teething may elevate temperature ≤0.5°C but does not cause rhinorrhea, cough, or fever >38.0°C. In Shishir, such symptoms almost always indicate concurrent viral infection.

These misconceptions persist due to intergenerational knowledge transfer—but evidence-based practice demands we replace tradition with physiology. For example, the 2022 IAP Clinical Practice Guideline explicitly advises against topical oils, citing Cochrane Review evidence of harm.

Shishir is not merely a cultural marker—it is a biologically consequential season demanding tailored, science-guided care. By aligning interventions with infant developmental physiology, regional climate data, and robust surveillance metrics, caregivers transform seasonal risk into an opportunity for proactive health optimization. Monitoring temperature gradients, optimizing air quality, respecting immunologic timelines, and recognizing true clinical urgency empowers families to navigate Shishir safely. As frontline nurses, our role extends beyond treatment: it is to translate epidemiology into actionable routines—whether selecting a 2.5 TOG sleep bag, calibrating a hygrometer, or explaining why steam inhalation poses greater danger than congestion itself. These decisions, grounded in measurement and evidence, form the bedrock of infant resilience during the frost season.

Real-world application begins with precision: measuring room temperature at crib height, verifying ORS osmolarity labels, checking expiration dates on palivizumab vials (must be used within 6 hours of reconstitution), and confirming pulse oximeter probe fit (infant-specific sensors reduce motion artifact by 63% vs. adult probes). Such granular attention transforms abstract guidelines into lifesaving practice.

Finally, caregiver well-being directly impacts infant outcomes. Pediatric nursing data from Sir Ganga Ram Hospital shows maternal stress scores (PSS-10) rise 40% during Shishir, correlating with delayed recognition of respiratory distress. Therefore, supporting parental rest, nutrition, and mental health is not ancillary—it is integral to Shishir-season care.

Seasonal patterns are not inevitable—they are modifiable through informed action. When a mother in Amritsar adjusts her baby’s layers based on real-time hygrometer readings, when a nurse in Hyderabad verifies palivizumab lot numbers before administration, when a father in Bengaluru replaces incense with HEPA filtration—all contribute to measurable reductions in infant morbidity. That is the tangible, daily work of Shishir-responsive care.

The data is unequivocal: targeted interventions during this 60-day window yield outsized returns in infant health outcomes. RSV hospitalization rates drop where HEPA filters are standard. Thermoregulation improves where layered clothing replaces swaddling blankets. And timely recognition—backed by WHO respiratory rate thresholds and validated oximetry—saves lives. This is not theoretical. It is practiced, measured, and refined daily in clinics and homes across India.

For healthcare providers, integrating Shishir-specific parameters into electronic health records—such as ambient temperature alerts at triage or automatic palivizumab reminder flags for eligible infants—can institutionalize seasonal responsiveness. For families, keeping a simple log—room temperature, humidity, feeding volumes, respiratory rate—creates an objective baseline for identifying deviation.

Shishir reminds us that environment and biology interact continuously. Our responsibility is to understand that interaction deeply—and act accordingly.

Infants do not experience seasons abstractly. They feel the dry air in their throats, the chill on uncovered skin, the effort of breathing through narrowed airways. Our clinical response must match that physiological reality—with precision, compassion, and unwavering commitment to evidence.

This season demands nothing less than our most vigilant, most informed, most human care.

Because every degree of temperature, every milligram of antibody, every percentage point of humidity matters—not as data points, but as the foundation of infant well-being.

And in Shishir, that foundation is built daily, deliberately, and with profound respect for the science of early life.

It is not about enduring the cold. It is about nurturing warmth—physiological, relational, and scientific—in its most essential forms.

That is the standard we uphold, season after season.